ライフサイエンスコーパス: alternative drug

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 atients received cross-over therapy with the alternative drug (61 topotecan, 49 paclitaxel) as third-

2 Alternative drug administration schemes and variable tum

3 findings emphasize the urgency of developing alternative drugs against influenza virus infection.

4 A multifaceted intervention, including alternative drug and other therapies for depression and

5 sistance and reinforces the need to evaluate alternative drugs and strategies for the control of mala

6 ve been developed using different platforms, alternative drugs, and either more biocompatible durable

7 dy, a number of patients crossed over to the alternative drug as third-line therapy, ie, from paclita

8 ures of T. cruzi CYP51 in complexes with two alternative drug candidates, pyridine derivatives (S)-(4

9 in children, including improved techniques, alternative drug combinations, as well as prospective in

10 few data exist on the cost effectiveness of alternative drug-eluting stent (DES) designs.

11 s that reduce coronary restenosis, including alternative drug-eluting stent platforms.

12 0.29%-1.19%]) compared with those receiving alternative drug-eluting stents.

13 in declined, confirming the utility of these alternative drugs for enteric fever treatment.

14 Risks associated with alternative drugs in the same class, including clarithro

15 s, is unsuitable for mass administration, an alternative drug is needed urgently.

16 The selection of structurally different alternative drugs is important to avoid recurrence.

17 , etc.), extrarenal allograft recipients, or alternative drug regimens such as steroid or MMF elimina

18 otential use of correlated reaction sets for alternative drug target identification.

19 surfaced exposed pocket on the AR-DBD as an alternative drug-target site for AR inhibition.

20 ity of patients with this cancer; therefore, alternative drug targets, including epigenetic enzymes,

21 ighlighting relevant drug-drug interactions, alternative drugs that can be safely used are suggested.

22 Alternative drugs that target bacterial virulence withou

23 These could become the targets of future alternative drug therapies to slow down the spread of an

24 to guide modelling and simulation to predict alternative drug therapies.

25 nciclovir-resistant strains disappeared with alternative drug therapy.

26 ihydroartemisinin-piperaquine is a promising alternative drug to replace sulfadoxine-pyrimethamine fo

27 tle information about the efficacy of active alternative drugs to carbapenems except beta-lactam/beta

28 nostic measures, potential cross-reactivity, alternative drugs to prescribe, and where more detailed

29 Because of the atypical demographics and the alternative drug use patterns, this young population of

30 etic overlap between diseases and predicting alternative drug use.

31 etic overlap between diseases and predicting alternative drug use.Computation can also be used to mod

32 Alternative drug-use strategies such as mixing, in which

33 reased efforts should be made to ensure that alternative drugs will be available for prevention of ma

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。